ArticleSchizophrenia (Heidelberg, Germany)2024

Exploring the molecular targets of fingolimod and siponimod for treating the impaired cognition of schizophrenia using network pharmacology and molecular docking.

Chao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.